Drug Pipeline News

>

Latest News

FDA will not meet original PDUFA data for sebetralstat to treat HAE | Image Credit: Contemporary Pediatrics
FDA will not meet original PDUFA date for sebetralstat to treat HAE

June 16th 2025

Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks.

FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis | Image Credit: Contemporary Pediatrics
FDA approves new presentation of ustekinumab-stba biosimilar for plaque psoriasis, psoriatic arthritis

June 16th 2025

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more
Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

June 13th 2025

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.
Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years

June 13th 2025

FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age | Image credit: Contemporary Pediatrics
FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age

June 12th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.